DexCom
DXCM
DXCM
414 hedge funds and large institutions have $10.5B invested in DexCom in 2018 Q4 according to their latest regulatory filings, with 105 funds opening new positions, 153 increasing their positions, 117 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
414
Holders Change
+51
Holders Change %
+14.05%
% of All Funds
9.24%
Holding in Top 10
11
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+57.14%
% of All Funds
0.25%
New
105
Increased
153
Reduced
117
Closed
52
Calls
$25.8M
Puts
$26.7M
Net Calls
-$868K
Net Calls Change
+$6.93M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$626M |
| 2 |
HM
HealthCor Management
New York
|
$176M |
| 3 |
BlackRock
New York
|
$609M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$1.04B |
| 5 |
Two Sigma Advisers
New York
|
$83.2M |
